Back to nne.com
With many considerations like the patient, GMP compliance and production, where do you begin when outlining a control strategy for pharma manufacturing?
Read how advanced statistical analytics methods can lead to 30% increase in average yield and 70% reduction in yield variation from batch to batch.
A robust control strategy is a good manufacturing practice ‘must.’ So how do you get started on establishing this interdisciplinary game plan?
QbD principles are still not the standard for all manufacturers’ pharmaceutical facility design. So why should the pharma industry take QbD more seriously?
Neglecting to develop a robust control strategy not only affects your business, but also holds severe consequences for the patient.
With this method, you can potentially convert 100 possible CPPs to a prioritized list of less than 10 CPPs.
Developing robust statistical process control (SPC) can do wonders for your quality control. Ensure its lucrative implementation with a successful pilot.
